SLDB
Solid Biosciences Inc. Common Stock
stockNASDAQ
Market OpenOct 5, 2026 2:40:11 PM EDT
7.15USD+4.380%(+0.30)657,784
7.1500Bid7.1600Ask0.0100SpreadLoading…
Loading…
767.20M
Healthcare
Biotechnology
HQ
Charlestown, MA, USA
Previous Close
$6.85
Beta
2.06
52-Week High
$11.45 2026-07-06
52-Week Low
$3.79 2025-11-07
SMA 50
$8.75
SMA 200
$7.59
Avg. Vol 10D
1.36M
Avg. Vol 30D
1.20M
Avg. Vol 90D
1.50M
Relative Vol
0.54
107.23M
78.20M
72.93%
17,106,152
21.88%
19.63
66%/34%
61.50%
36.15%
0.3800%
700,000
953
1,908
6,166
Nov 2, 2026 (28d)
Oct 28, 2022 · 1-for-15 (reverse)
Oct 1, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · 
GlobeNewswire Inc.
Sep 16, 2026
Solid Biosciences wins new Outperform at RBC on DMD opportunity · 
Seeking Alpha
SLDB Profile
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
SLDB Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 7.28 | 2026-09-28 | -1.72% | -1.880 |
| 1M | 10.25 | 2026-09-04 | -30.20% | 0.363 |
| 3M | 11.07 | 2026-07-06 | -35.37% | 1.641 |
| 6M | 7.74 | 2026-04-06 | -7.56% | 1.847 |
| 1Y | 5.48 | 2025-10-06 | +30.57% | 2.064 |
| 2Y | 6.58 | 2024-10-04 | +8.74% | — |
| 5Y | 35.25 | 2021-10-05 | -79.70% | 1.354 |
SLDB Stock Summary
Solid Biosciences Inc. Common Stock (NASDAQ:SLDB) stock price today is $7.16, and today's volume is 654,608. SLDB is up 4.453% today. The 30 day average volume is 1.20M. SLDB market cap is $767.20M with 107.23M shares outstanding.